Hearing implants are surgically installed devices aimed at improving the hearing capability of a person suffering from severe or profound levels of hearing loss. The main types of hearing implants devices and equipment are cochlear implants, middle ear implants, bone conduction implants, and auditory brainstem implants. A cochlear implant is an electronic device that partially restores hearing. It is an option for people who have severe hearing loss from inner-ear damage and are no longer helped by using hearing aids. These are used by age groups such as adults and pediatrics. The various end-users are hospitals, ENT clinics, and ambulatory surgical centres. The hearing implants devices and equipment market research report is one of a series of new reports from The Business Research Company that provides hearing implants devices and equipment market statistics, including hearing implants devices and equipment industry global market size, regional shares, competitors with a hearing implants devices and equipment market share, detailed hearing implants devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the hearing implants devices and equipment industry. This hearing implants devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global hearing implants market size will grow from $3.95 billion in 2022 to $4.4 billion in 2023 at a compound annual growth rate (CAGR) of 11.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The hearing implants market size is expected to grow to $6.36 billion in 2027 at a CAGR of 9.7%. The aging population is increasing worldwide and loss of hearing is one of the most common age-related disorders in the aged above 60 years. As reported by United Nations, in 2020, there are 727 million people aged 65 years in the world and with the increasing geriatric population, the demand for hearing implants is expected to rise. Therefore, the increasing aging population is expected to drive the market for hearing implants in the future. The surgical procedure for implanting hearing implants is associated with various risks and is expected to restraint the market growth in the future. During the surgery, there are possibilities of facial nerve damage which can lead to complete or partial paralysis on the same side of the face as the implant. Due to this and other complications such as the development of meningitis, cerebrospinal fluid leakage, infection, and others, people prefer conventional hearing aids over implants. Hence, restraining the growth of the hearing implants market. Companies in the hearing implants market are making implants using 3D printing in binaural cochlear surgeries. The technology focuses on developing customized 3D printed implants using biocompatible materials to treat anatomical defects with the help of stem cells. Sonova manufactures binaural cochlear implants, which use two different modes of stimulation, electrical and acoustic to enhance hearing and better discrimination of speech. Further, in 2020, scientists developed a 3D-microscaffold cochlear implant using a 3D printed steroid reservoir was designed to reduce the damage of residual hearing against electrode insertion trauma. Cochlear implant manufacturers have to submit information regarding the material used, efficacy based on clinical trials, any adverse effects to the FDA. The manufacturer can begin the sale of the implants in the USA only after receiving approval from the FDA. Major players in the hearing implants devices and equipment market are Sonova (Switzerland), Advanced Bionics AG (Switzerland), Siemens AG, William Demant Holding Group (Denmark), Microson S.A. (Spain), RION, SeboTek Hearing Systems, Arphi Electronics, Widex A/S, and Audina Hearing Instruments. North America was the largest region in the global hearing implants devices and equipment market in 2022. Asia-Pacific was the second-largest region in the hearing implants devices and equipment market. The regions covered in the global hearing implants devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the hearing implants devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The hearing implants market consists of sales of cochlear implants, bone anchored hearing aids (BAHA), mid-ear implants, and auditory brainstem implants (ABI) that are used to improve hearing capability. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global hearing implants market is segmented - 1) By Type: Cochlear Implants, Middle Ear Implants, Bone Conduction Implants, Auditory Brainstem Implant 2) By End-User: Hospitals, ENT clinics, Ambulatory Surgical Centres 3) By Age: Adult , Pediatric

Spine implants are the devices used to correct the deformity in the spine, stabilise and strengthen the spine, and facilitate the fusion of bones in different disorders such as degenerative disc disease, kyphosis, scoliosis, spondylolisthesis, spinal stenosis, and fracture. The main products in the spine implant market are spinal fusion devices, non-fusion devices/motion preservation devices, vertebral compression fracture (VCF) treatment devices, spinal bone stimulators, and spine biologics. The spinal fusion devices provide a solution for spinal instability and are designed specifically to treat spinal disorders. They use surgical procedures to implant titanium-alloy, titanium, stainless steel, and non-metallic devices into the spine. Open surgery and minimally invasive surgery (MIS) are among the procedures involved.The various materials in spine implants include metallic, polymeric, and ceramic. The spinal implants are used in hospitals, specialty orthopaedic and spine centres, and ambulatory surgical centres. The spine implants market research report is one of a series of new reports from The Business Research Company that provides spine implants market statistics, including spine implants industry global market size, regional shares, competitors with a spine implants market share, detailed spine implants market segments, market trends and opportunities, and any further data you may need to thrive in the spine implants industry. This spine implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global spine implants market grew from $11.32 billion in 2022 to $12.33 billion in 2023 at a compound annual growth rate (CAGR) of 8.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The spine implants market is expected to grow from $16.86 billion in 2027 at a CAGR of 8.1%. The rising incidences of spinal disorders coupled with the usage of minimally invasive surgical procedures are contributing to the growth of the global spinal implants market. According to Branko PRPA, surgical in September 2021, annually there are 1.34 to 4.6 spinal cases per million and 1,400 new cases diagnosed each year, with 33,000 having some type of disability in the US and among them, 30% of the adult female population suffers from lower back pain, compared to 25 percent of the adult male adult population and this is approximately 31% of men acknowledged that their condition affects their employment compared to 20% of women. In 2021, the prevalence of neuropathic pain was found to be between 16% and 55%. And due to the emergence of minimally invasive spine surgical (MISS) approaches, it has now become feasible and efficient for treating a wide range of spinal disorders without long incisions and by avoiding significant damage to muscles surrounding the spine, thereby resulting in fewer post-operative pains and faster recovery. Therefore, the increased prevalence of spinal disorders along with the ease in treatment by MISS approaches is driving the global spinal implants market. The increased treatment procedural cost is acting as a hindrance to the global spinal implants market growth. According to a study published in 2021, approximately 500,000 lumbar spine surgeries were performed in the US. The cost of spinal surgeries has increased by 175% globally and in the US, the annual cost of spine care is estimated at $105 billion per patient annually. Increased treatment procedural costs will increase monetary concerns, limiting the market growth. The innovation of implants in providing minimally invasive and motion-preserving stabilization is a major trend in the spine implants market. For example, RTI Surgical Holdings, a global surgical implant company, has launched the first and only posterior lumbar motion preservation solution, Coflex. Coflex is a differentiated, minimally-invasive, motion-preserving stabilization implant that is FDA PMA-approved for the treatment of moderate to severe lumbar spinal stenosis (LSS). It can be directly implanted following a surgical decompression, without fusing the bones. The device comes in different sizes to fit the patient’s anatomy, and this can be performed even in an outpatient setting. In July 2022, Spineway, a France-based spinal implants manufacturer acquired Spine Innovations for an undisclosed amount. The acquisition would help Spineway to accelerate its innovation and growth and position itself as a leader in this segment. Spinal Innovations is a French manufacturer of spinal implants. Major players in the spine implants market are Medtronic, Depuy Synthes, Johnson & Johnson, Stryker Corporation, NuVasive, Inc., Zimmer Biomet Holdings, Globus Medical, Alphatec Holdings, Orthofix International, and RTI Surgical. North America was the largest region in the spine implants market in 2022. Western Europe was the second largest region in the global spine implants market report. The regions covered in the global spine implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the spine implant market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The spine implants market consists of sales of cages, plates, rods values, artificial disc and expandable rods. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organisations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products. The global spine implants market is segmented - 1) By Product: Spinal Fusion Devices, Non-Fusion Devices/Motion Preservation Devices, Vertebral Compression Fracture (VCF) Treatment Devices, Spinal Bone Stimulators, Spine Biologics 2) By Procedure: Open Surgery, Minimally Invasive Surgery (MIS) 3) By Material: Metallic, Polymeric, Ceramic 4) By End Use: Hospitals, Specialty Orthopedic And Spine Centers, Ambulatory Surgical Centers

Dental implants are medical devices surgically implanted into the jaw to restore a person's ability to chew or their appearance. The main products of dental implants are tapered implants and parallel walled implants. A tapered implant is a cylindrical implant in which the endosseous part is narrow in diameter towards the apex. The dental implants are made up of materials such as titanium and zirconium that are used by various end-users, such as hospitals and dental clinics. The dental implants market research report is one of a series of new reports from The Business Research Company that provides dental implants market statistics, including dental implants industry global market size, regional shares, competitors with a dental implants market share, detailed dental implants market segments, market trends and opportunities, and any further data you may need to thrive in the dental implants industry. This dental implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global dental implants market grew from $6.21 billion in 2022 to $6.86 billion in 2023 at a compound annual growth rate (CAGR) of 10.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The dental implants market is expected to grow from $9.85 billion in 2027 at a CAGR of 9.4%. The rising prevalence of dental caries that require dental implants for treatment increase the demand for dental implants. Dental caries is a multifactorial, chronic condition arising from various causes such as nutrition, saliva, micro-organisms, trace minerals, genetic predisposition, and tooth morphology leading to tooth decay. According to a research survey published on BMC healthcare research, an open access research article publisher, in 2021, the prevalence of dental caries in primary and permanent teeth was found to be 41.1% and 68.9% respectively. Dental implants have also become popular as an alternative to removable dentures and are used to replace lost teeth. As a result, the increasing demand for dental implants to replace lost teeth stimulates market growth. The high cost of dental implants is a key factor hampering the growth of the dental implants market. Dental implants are a form of dental surgery that involves multi-stage surgery and are one of the costliest dental procedures to repair false teeth. For instance, dental implants cost an average of between $3,000-$4,500 per tooth in the USA, including total implant size, abutment and crown, and bone graft, which is often needed, cost an additional $200-$3,200. The high cost of dental implants makes them unaffordable for medium and low-income groups obstructing the growth of the dental implants market. Dental implant technology has advanced with the introduction of new technologies and equipment, which improve the consistency and quality of implant treatment. Companies are manufacturing implants that suit the patients’ aesthetics. For instance, in June 2022, ZimVie launched T3 Pro Tapered implant and Encode® Emergence Healing Abutment. The products were designed keeping in mind the products provide both restorative care and aesthetics as well. In 2020, Keystone Dental, a US-based dental implant company, acquired Osteon Medical for an undisclosed amount. This acquisition is providing Keystone with a synergistic sales opportunity to expand in the $5 billion dental implant market. Osteon Medical is an Australia-based company manufacturer of dental implants. Major players in the dental implants market are Zimmer Biomet Holdings Inc., OSSTEM IMPLANT, Institut Straumann AG, Bicon LLC, DENTSPLY Sirona, Danaher Corporation, BioHorizons IPH Inc., Shofu Dental Corporation, Thommen Medical AG, and Ivoclar Vivadent Inc. Asia-Pacific was the largest region in the dental implant market in 2022. Western Europe was the second-largest region in the global dental implant market report. Africa. was the smallest region in the global dental equipment and supplies market. The regions covered in the global dental implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the dental implants market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. Dental implants consist of sales of implants such as endosteal implants, subperiosteal implants, and transosteal implants. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organisations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products. The global dental implants market is segmented - 1) By Product: Tapered Implants, Parallel Walled Implants 2) By Material: Titanium, Zirconium 3) By End-use: Hospitals, Dental Clinics

Cranial implants are used for protecting intracranial structure, reconstructing the skull shape, normalizing cerebral hemodynamics, and also during cranial reconstruction procedures after cranial defects. The main types of cranial implants include customized and non-customized cranial implants. A customized implant is transplanted into the wound and then transforms its shape when the temperature, pressure, or magnetic field changes, to adapt to the dimensions of tissue defects. A polymer is a large molecule or a macromolecule which essentially is a combination of many subunits. The main types of material used for manufacturing cranial implants are polymer, metal, and ceramic and are used in hospital and trauma centers, ambulatory surgical centers, speciality clinics, and others. The cranial implants market research report is one of a series of new reports from The Business Research Company that provides cranial implants market statistics, including cranial implants industry global market size, regional shares, competitors with a cranial implants market share, detailed cranial implants market segments, market trends and opportunities, and any further data you may need to thrive in the cranial implants industry. This cranial implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global cranial implants market size grew from $1 billion in 2022 to $1.1 billion in 2023 at a compound annual growth rate (CAGR) of 10.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The cranial implants market size is expected to grow to $1.45 billion in 2027 at a CAGR of 7.1%. The rising prevalence of neurological diseases and road accidents is expected to propel the growth of the cranial implants market in the forecast period. According to Parkinson's disease statistics, Parkinson's disease is the second most common age-related neurological disorder after Alzheimer's disease. A cranial implant will enable doctors to look inside the brain without having to drill a new hole in the skull each time, making neurological disorder treatment easier. According to Parkinson's Foundation, in 2020, approximately one million cases were suffering from Parkinson's disease (PD) in the U.S. According to the world health organization, approximately 1.35 million people die every year from road accidents. Accidents cause a skull fracture, brain damage, and other related conditions. Therefore, the rising prevalence of neurological diseases and road accidents is driving the growth of the cranial implants market. 3D printing is an emerging technology in the cranial implants market. 3D printing is the method of making three-dimensional solid objects from digital data. For instance, in 2020, Graz University of Technology (TU Graz) and the Medical University of Graz in Austria, released a free automated design software to design 3D printable cranial implants. The program utilizes deep learning algorithms to automatically replace the missing portion of a skull. An STL file for a patient-specific implant can immediately be generated by decreasing the defective skull from the performed one. This process allows implants to be 3D printed on-site and drastically reduces the actual lead time. In July 2020, Medtronic plc, a US-based medical device company that offers surgical devices, respiratory monitoring systems, medical equipment, and other equipment acquired Medicrea for a value of $ 8.2 (€7.00) per Medicrea share. This acquisition would increase Medtronic’s position as a global innovator in licensing technologies and solutions for spine surgery. Medicrea is a US manufacturer of medical devices and offers a variety of implants for the cervical spine and bone substitutes for the thoracic spine. Major players in the cranial implants market are B. Braun Melsungen AG, DePuy Synthes (Johnson and Johnson), Stryker Corporation, Zimmer Biomet, Kelyiniam Global Inc., Medartis AG, Osteomed, KLS Martin Group, Renishaw PLC., Xilloc Medical B.V., Medtronic, Ortho Baltic, Evonos, and Synimed. North America was the largest region in the cranial implants market in 2022. Asia-Pacific is predicted to record the fastest growth over the forecast period. The regions covered in the cranial implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the cranial implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The cranial implants market consists of sales of titanium implants, synthetic bone implants, and solid biomaterials. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global cranial implants market is segmented - 1) By Type: Customized Cranial Implants, Non-customized Cranial Implants 2) By Material: Polymer, Ceramic, Metal 3) By End User: Hospital and Trauma Centers, Ambulatory Surgical Centers, Speciality Clinics, Other End-Users

Ocular implants are used to improve eye vision of a person. These implants help improve the fixing sight of people who have lost an eye to injury or disease, commonly called a glass eye, made up of hard plastic acrylic. The prosthetic eye has a shell form, consisting of a clear, artificial lens implant, used to replace a cloudy natural lens in cataract surgery. The main types of products in ocular implants are intraocular lens, corneal implants, orbital implants, glaucoma implants and others. The intraocular lens are made from chemicals or artificial substances such as clear plastic, silicone, or acrylic. It bends (refracts) light rays that enter the eye, helping one to see. They are coated with a special material that can help to protect your eyes from the harmful ultraviolet rays emitted by the sun. These ocular implants are used in glaucoma surgery, diabetic retinopathy and age-related macular degeneration by end-user such as specialty eye institutes, hospitals and clinics. The ocular implants market research report is one of a series of new reports from The Business Research Company that provides ocular implants market statistics, including ocular implants industry global market size, regional shares, competitors with a ocular implants market share, detailed ocular implants market segments, market trends and opportunities, and any further data you may need to thrive in the ocular implants industry. This ocular implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global ocular implants market size grew from $12.03 billion in 2022 to $12.98 billion in 2023 at a compound annual growth rate (CAGR) of 8.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The ocular implants market size is expected to grow to $17.66 billion in 2027 at a CAGR of 8.0%. The increase in prevalence of eye disorders across the world is going to be a major driver in the growth of the ocular implants market. The foremost common eye disorders within the U.S. Isis refractive errors. For instance, in 2022 in line with American Academy of Ophthalmology (AAO) offer statistics on the prevalence of visual defect because of eye disorders by ethnicity yet because the breakdown of individuals who are legally blind thanks to eye diseases or eye disorders by grouping. Within the united statesUnited States alone, about 12 million people ageaged 40 and above suffer from vision impairment, with about a million full of blindness globally, the similar reports about 2.2 billion individuals have eye and visual disorders, according to the world health organization. Hence, the rising prevention of eye disorders, is anticipated more demand for ocular implants increasing prevalence of eye disorders like cataract and glaucoma is to fuel the demand for ocular implants. Technological advancements and innovations has been a key trend gaining popularity in the ocular implants market. Technological advancements are the discovery of knowledge that helps in developing products using advanced technology. Major companies operating in the ocular implants market are focused on developing new technological solutions to meet customer demand and make ocular implants more advanced. For instance, In July 2021, ZEISS, a Germany-based manufacturer of optical systems and optoelectronics, introduced the ZEISS Medical Ecosystem. The ZEISS Medical Ecosystem is an entirely integrated setting that uses various tools for data management, apps, and services to enhance patient outcomes continuously. This ecosystem's unique combination of unmatched ocular knowledge and cutting-edge digital technology makes it possible to make decisions based on the best available data, ensuring the most effective treatment delivery on a single, secure platform. in 2019 France based bioelectronics and brain-machine interface technology company PIXIUM VISION recently introduced PRIMA System artificial eye technology that partially replaces the normal physiological functioning of the photoreceptors of the eye, with a mini camera mounted on the glasses that captures visual scenes in the environment, which gets processed and simplified by the pocket computer, in order to extract meaningful information from the photos, using artificial intelligence breakthrough algorithms. In patients, 36 months after implantation, the PRIMA implant was well tolerated and safe. These observations are in line with Vitro reliability studies that showed the implants to be 100% reliable with the pixels reliability of over 90%, for over the past 20 years. In August 2021, Alcon, a Switzerland-based medical company offering dedicated eye care, announced acquisition of Ivantis®, $475 million in cash up front. The aim of this acquisition demonstrates Alcon's commitment to the surgical glaucoma market, bolstering the company's industry-leading portfolio in cataract, refractive, retina, and glaucoma. Ivantis® is a US-based company the developing and manufacturing the Hydrus® Microstent, a novel minimally invasive glaucoma surgery (MIGS) device the designed to lower intraocular pressure in open-angle glaucoma patients during cataract surgery. Major players in the ocular implants market are Alcon Inc., Bausch & Lomb Inc., Carl Zeiss AG, ZEISS International, STAAR Surgical Company, Morcher GmbH, Hoya Corporation, and Glaukos Corporation. North America was the largest region in the ocular implants market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ocular implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the ocular implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The ocular implants market consists of sales ofmonofocal lens, toric lens, multifocal and accommodating lenses. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global ocular implants market is segmented - 1) By Product: Intraocular Lens, Corneal Implants, Orbital Implants, Glaucoma Implants, Other Products 2) By Application: Glaucoma Surgery, Diabetic Retinopathy, Age-Related Macular Degeneration 3) By End-User: Specialty Eye Institutes, Hospitals, Clinics

Breast implants are breast-shaped bags constructed of a silicone outer shell and filled with silicone gel or saline, and they used to change the size, shape, and form of the breasts. The main types of breast implants are silicone implant, form-stable implant, saline implant, and structured saline implant. The silicone implant is filled with silicone gel. The silicone gel has a similar texture to genuine breast tissue. They are used by hospital, cosmetology clinic, and other end users in breast augmentation and breast reconstruction procedures. The breast implants market research report is one of a series of new reports from The Business Research Company that provides breast implants market statistics, including breast implants industry global market size, regional shares, competitors with a breast implants market share, detailed breast implants market segments, market trends and opportunities, and any further data you may need to thrive in the breast implants industry. This breast implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global breast implants market size grew from $2.26 billion in 2022 to $2.43 billion in 2023 at a compound annual growth rate (CAGR) of 7.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The breast implants market size is expected to grow to $3.17 billion in 2027 at a CAGR of 6.9%. Growing breast cancer incidences significantly contributed to the growth of the breast implants market. Breast cancer is a type of cancer in which cells lining the breast lobules and ducts grow abnormally. Breast cancer surgery is a key component in breast cancer treatment, which involves removing of cancer through operations. The different procedures used in breast cancer treatment includes surgery to remove entire breast or portion of breast tissue or nearby lymph nodes or others. Breast implants are used by breast cancer patients after surgery to regain the breast shape and size and regains the natural body appearance. For instance, according to the study published in World Cancer Research Fund International, the total number of new breast cancer cases across the globe accounted for 2.2 million in 2020 and accounted for 12.5% all cancer cases in 2020. Therefore, the growing breast cancer incidences is expected to promote the growth of the breast implants market during forecast period. Lightweight breast implants are the key trends gaining popularity in the breast implants market. The lightweight breast implant (LWBI) is around 30% lighter than typical silicone implants while retaining the same size, shape, and function. The LWBI reduces weight-related problems and reoperation rates by lowering stress on breast tissues and preserving tissue reliability and integrity over time. For instance, in September 2020, POLYTECH Health & Aesthetics GmbH, a Germany-based manufacturer of breast implants launched an extended B-Lite line, the world's first and only lightweight breast implant. These implants are 30% lighter and possess advantages such as quicker recovery, less stretching from movement, greater daily comfort, and reduced post-operative pain. B-Lite with MESMO fine-texturing surface and B-Lite with the distinctive Microthane shell coating is among the new shapes and surfaces in the extended range. In May 2020, AbbVie Inc., a US-based biopharmaceutical company acquired Allergan for $63 billion. This acquisition broadens, diversifies, and enriches AbbVie's portfolio by adding long-term franchises in various appealing therapeutic areas, including immunology and neuroscience. Allergan PLC. is Ireland-based drugs and medical devices manufacturing company that manufactures breast implants. Major players in the breast implants market are Sientra Inc., GC Aesthetics, HansBioMed Corp., Establishment Labs S.A., Silimed, AbbVie Inc., Groupe Sebbin SAS, Polytech Health & Aesthetics, Cereplas, Laboratoires Arion, Mentor Worldwide LLC, Johnson & Johnson (Mentor Worldwide LLC), Guangzhou Wanhe Plastic Materials, and Ideal Implant. North America was the largest region in the breast implants market in 2022. The regions covered in the breast implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the breast implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The breast implants market consists of sales of Saline-Filled Breast Implants, Silicone-Filled Breast Implants, and Breast Tissue Expanders. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global breast implants market is segmented - 1) By Type: Silicone Implant, Form-stable Implant, Saline Implant, Structured Saline Implant 2) By Procedure: Breast Augmentation, Breast Reconstruction 3) By End User: Hospital, Cosmetology Clinic, Other End Users

Veterinary orthopaedic implant is a surgical tool used to repair a broken bone structure and regain its function. Veterinary orthopaedic implants are typically made of metals such as pure commercial titanium (Ti) or titanium alloys, stainless steel, and cobalt-chromium (Co-Cr) alloys and are used by veterinary surgeons for bone fixation surgeries and treating bone fractures in animals.The orthopaedic implants are also used as a support structure for healing fractures and reconstructive surgeries. Orthopedic implants include screws, plates, pins, and wires, which are used in surgeries performed on animals. The main product types in veterinary orthopaedic implants are advanced locking plate systems, tibial plateau levelling osteotomy implants, tibial tuberosity advancement implants, total elbow replacement, total hip replacement, total knee replacement, and trauma fixations. A tibial plateau levelling osteotomy implants are used to repair cranial cruciate ligament ruptures in dogs. The veterinary orthopaedic implants are used for animals such as dogs and cats, as well as for end-users such as veterinary hospitals, clinics, and surgical centers. The veterinary orthopaedic implants market research report is one of a series of new reports from The Business Research Company that provides veterinary orthopaedic implants market statistics, including veterinary orthopedic implants industry global market size, regional shares, competitors with a veterinary orthopaedic implants market share, detailed veterinary orthopaedic implants market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary orthopaedic implants industry. The veterinary orthopaedic implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global veterinary orthopedic implants market grew from $0.22 billion in 2022 to $0.24 billion in 2023 at a compound annual growth rate (CAGR) of 8.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The veterinary orthopedic implants market is expected to grow from $0.32 billion in 2027 at a CAGR of 7.2%. The increase in the incidence of obesity and arthritis increases the demand for veterinary orthopaedic implants market. Obesity is a condition where the weight of the pet affects the pet's health to a point where it results in the weakening of bones, whereas arthritis in pets results in loss of strength in bones. Obesity and arthritis may also result in fractures, and other bone-joint-related issues and both conditions result in adversely affect the overall health of the pet, consequently leading to shortening lifespan. Thus, the increased incidents of obesity and arthritis increase the demand for veterinary orthopaedic implants. According to Banfield Pet Hospital’s report on 2.5 million dogs and 500,000 cats treated in the USA, the number of osteoarthritis (OA) cases increased 66% in dogs and 150% in cats. The report also inferred that 52% of dogs and 41% of cats with OA are also overweight or obese. Thus, the increase in health conditions affecting the bones of pets such as obesity and arthritis positively affect the growth of the veterinary orthopaedic market. The high cost of orthopaedic surgery inhibits the growth of the veterinary orthopaedic implants market. The surgery cost includes the equipment, X-ray, and consumables among others, which many of the households cannot afford. For instance, in the USA, a typical examination of the problem costs around $400 and the cost of orthopaedic surgery ranges from $1,500 to $4,000. Thus, the high cost of orthopaedic surgery restricts the growth of the veterinary orthopaedic market. The companies in the veterinary orthopaedic implants market are investing in 3D printing techniques for creating veterinary orthopaedic implants. 3D printing in the veterinary orthopaedics market is being used for creating printed bone models, surgical guides, and titanium implants. The use of 3D printing reduces the surgical time, and cost and removes the engineering complexities in orthopaedic procedures. Following the trend, many dogs with bone deformities have been treated by Langford Veterinary Services, a UK-based provider of veterinary services, through its collaboration with CBM. The collaboration enabled CBM to create 3D printed models of animal implants using titanium Ti6AI4V EL material. The MRI or CT scans are sent from Langford Veterinary Services in Bristol to CBM, then produces 3D printed models using Arcam EBM Q10plus machine. CBM is a U.K based company focused on advanced research, product development, and batch manufacturing facility. Thus, the use of 3D printing is one of the latest trends in the veterinary orthopaedic implants market and will contribute to the growth of the market. In August 2022, Vimian Group, a Sweden-based animal health company, acquired New Generation Devices’ assets. The acquisition, Vimian will get access to a new customer base, which they can tap to increase their revenues. New Generation Devices is a veterinary orthopaedic implant manufacturer based in the United States that was founded in 2002. Major players in the veterinary orthopaedic implants market are KYON Pharma Inc., Veterinary Orthopedic Implants Inc., BioMedtrix LLC., IMEX Veterinary Inc., Orthomed Ltd., Securos Surgical, B. Braun Vet Care, Bluesao, DePuy Synthes Vet, and MWI Veterinary Supply Co. North America was the largest region in the veterinary orthopaedic implants market in 2022. Western Europe was the second largest region in the global veterinary orthopaedic implants market report. The regions covered in the global veterinary orthopaedic implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the veterinary orthopaedic implants are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The veterinary orthopedic implant market consists of sales screws, plates, pins, and wires. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products. The global veterinary orthopedic implants market is segmented - 1) By Product Type: Advanced Locking Plate System, Tibial Plateau Leveling Osteotomy Implants, Tibial Tuberosity Advancement Implants, Total Elbow Replacement, Total Hip Replacement, Total Knee Replacement, Trauma Fixations 2) By Animal: Dog, Cat, Other Animals 3) By End-User: Veterinary Hospitals, Veterinary Clinics, Veterinary Surgical Centers

Medical equipment are devices that can be instrument, apparatus or machine that can be used in the prevention, diagnosis or treatment of illness or disease, or for detecting, measuring, restoring, correcting or modifying the structure or function of the body for health purpose. The main types of medical equipment are in-vitro diagnostics, dental equipment and supplies, ophthalmic devices, diagnostic imaging equipment, cardiovascular devices, hospital supplies, surgical equipment, orthopedic devices, patient monitoring devices, diabetes care devices, nephrology and urology devices, ENT devices, anesthesia and respiratory devices, neurology devices, and wound care devices. In-vitro diagnostics are tests done on samples like blood or tissue that is taken from the human body. In-vitro diagnostics will detect diseases or other conditions and are used to monitor a person’s overall health to cure, treat, or prevent diseases. The type of expenditure involved is public and private. The various product are instruments/equipment and disposables. The various end users involved are hospitals and clinics, homecare, diagnostics centres, and others. The medical equipment market research report is one of a series of new reports from The Business Research Company that provides medical equipment market statistics, including medical equipment industry global market size, regional shares, competitors with a medical equipment market share, detailed medical equipment market segments, market trends and opportunities, and any further data you may need to thrive in the medical equipment industry. This medical equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global medical equipment market grew from $639.75 billion in 2022 to $695.05 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The medical equipment market is expected to grow to $922.39 billion in 2027 at a CAGR of 7.3%. The rise in sedentary jobs, busy lifestyles, and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as cancer, diabetes, and cardiovascular diseases. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of chronic diseases such as diabetes. According to the World Health Organization, chronic disease prevalence is expected to rise by 57% globally, by the year 2020. This is increasing the demand for medical devices used in the diagnosis, prognosis, and treatment of several diseases, thereby driving the demand for medical equipment. These factors are expected to increase the patient pool globally, thereby driving the market during the forecast period. Regulatory changes are likely to lead to increased costs relating to new product development and service offerings to clients. These changes are related to customer data protection such as the European Union's General Data Protection Regulation (GDPR), changes to equipment approval procedures, and other regulatory changes. For instance, according to cookieyed data 2021, in the US, PwC reported that 68% of 200 businesses surveyed intended to spend between $1 million and $10 million to comply with GDPR regulations. The GDPR regulation is an EU law on data protection and privacy of individuals residing in the European Union and the European Economic Area (EEA). It also regulates the export of personal data outside the EU and EEA areas. Additionally, the FDA is requesting more clinical data to support claims, therefore increasing the time to process 510(k)s by over 55% over the last decade. The potential loss of revenue due to delays in product release and additional costs incurred due to stringent approval processes puts a strain on investments relating to new product development, thereby affecting the growth of the medical equipment market. Device performance and patient data are available to healthcare service providers and are helping them to improve patient monitoring and overall care quality. Some companies are integrating medical device data with EMR (Electronic Medical Records) to improve transparency and collaboration. As consumer wearables are becoming more common, patient data volumes are increasing and companies are investing in deploying data management, warehousing, and security technologies. For example, Medtronic launched a tool to augment their cardiac devices to securely transfer device data to doctors and allow them to monitor the critical health indicators of their patients. Major companies in the medical equipment market include Medtronic Inc., Abbott Laboratories, Johnson & Johnson, Cardinal Health, Inc., Becton Dickinson, Siemens AG, STRYKER CORPORATION, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., and Boston Scientific Corporation. North America was the largest region in the global medical equipment market in 2022. Asia-Pacific was the second largest region in the global medical equipment market. The regions covered in the medical equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the medical equipment market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The medical equipment market consists of sales of devices used in the diagnosis, treatment and monitoring of medical conditions. The market includes diagnostic devices, imaging devices, surgical devices and patient monitoring devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global medical equipment market is segmented - 1) By Type: In-Vitro Diagnostics, Dental Equipment And Supplies, Ophthalmic Devices, Diagnostic Imaging Equipment, Cardiovascular Devices, Hospital Supplies, Surgical Equipment, Orthopedic Devices, Patient Monitoring Devices, Diabetes Care Devices, Nephrology And Urology Devices, ENT Devices, Anesthesia And Respiratory Devices, Neurology Devices, Wound Care Devices 2) By Type of Expenditure: Public, Private 3) By Product: Instruments/Equipment, Disposables 4) By End User: Hospitals And Clinics, Homecare, Diagnostics Centers, Other End Users Subsegments Covered: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment, Therapeutic Dental Equipment, General Dental Devices And Equipment, Dental Diagnostic Imaging Devices And Equipment, Dental Surgical Devices And Equipment, Vision Care Devices And Equipment, Cataract Surgery Devices And Equipment, Refractive Surgery Devices And Equipment, Diagnostic And Monitoring Ophthalmic Devices And Equipment, X-Ray Systems Devices And Equipment, Ultrasound Systems Devices And Equipment, Computed Tomography (CT) Scanners Devices And Equipment, Magnetic Resonance Imaging Systems Devices And Equipment, Cardiovascular Monitoring And Diagnostic Devices And Equipment, Nuclear Imaging Devices And Equipment, Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment, Disposable Hospital Supplies, Sterilization Equipment And Disinfectants, Mobility Aids And Transportation Equipment, Operating Room Equipment, Surgical Sutures And Staples, Handheld Surgical Devices And Equipment, Electrosurgical Devices And Equipment, Joint Reconstruction Devices And Equipment, Spinal Surgery Devices And Equipment, Trauma Fixation Devices And Equipment, Orthobiologics Devices And Equipment, Arthroscopy Devices And Equipment, Orthopedic Braces And Support Devices And Equipment, Craniomaxillofacial (CMF) Devices And Equipment, Orthopedic Prosthetics, Orthopedic Accessories,, Fetal And Neonatal Monitoring Devices, Weight Monitoring And Body Temperature Monitoring Devices And Equipment, Vital Parameter Monitoring Devices And Equipment, Remote Patient Monitoring Devices And Equipment, Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters, Dialysis Devices And Equipment, Urinary Stone Treatment Devices And Equipment, Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment, Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment, Endoscopy Devices And Equipment, Hearing Aid Devices And Equipment, Hearing Diagnostic Devices And Equipment, ENT Surgical Devices And Equipment, Hearing Implants, Voice Prosthesis Devices And Equipment, Nasal Splints, Respiratory Devices And Equipment (Therapeutic And Diagnostic), Anesthesia Machines, Anesthesia Disposables, Respiratory Disposables, Cerebrospinal Fluid Management (CSF) Devices And Equipment, Interventional Neurology Devices And Equipment, Neurosurgery Devices And Equipment, Neurostimulation Devices, Traditional Adhesive Dressings, Negative-pressure Wound Therapy (NPWT), Traditional Gauze Dressings, Advanced Wound Care Devices